<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53473">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01684631</url>
  </required_header>
  <id_info>
    <org_study_id>27062008</org_study_id>
    <nct_id>NCT01684631</nct_id>
  </id_info>
  <brief_title>Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement</brief_title>
  <official_title>Prospective, Multicentric, Observational Cohort Study for the Evaluation of Implant Survival in Patients With a Metal-on-Metal Pinnacle(R) Ultamet(TM) Device in Conventional Total Hip Joint Replacement.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy International</source>
  <oversight_info>
    <authority>France: Ministère de l'Enseignement supérieur et de la Recherche</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to evaluate the implant survival rate for patients implanted with a
      PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the
      treatment of a severe hip disease and true femoral cervical fracture.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Implant Survival Rate</measure>
    <time_frame>up to 5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Implant Survival Rate as the duration of PINNACLE® ULTAMET™ implantation for the follow-up duration, free of revision surgery, whatever the cause.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>pre-operative, 1, 2, 3, 5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure of hip function using the Harris Hip Score</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cobalt and Chromium serum concentration</measure>
    <time_frame>3 to 6 Months, 1, 2, 3, 5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive analysis of patient serum concentration of Cobalt and Chromium</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Event Frequency</measure>
    <time_frame>Per-operative, 3 to 6 Months, 1, 2, 3, 5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Descriptive Analysis of Adverse Event Frequency for the duration of the study.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Arthropathy of Hip</condition>
  <arm_group>
    <arm_group_label>Hip arthroplasty</arm_group_label>
    <description>Patients implanted with a PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the treatment of a severe hip disease or true femoral cervical fracture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Hip arthroplasty</intervention_name>
    <arm_group_label>Hip arthroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients susceptible to receive a PINNACLE® ULTAMET™ implant
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients susceptible to receive a PINNACLE® ULTAMET™ implant as per routine practice

        Exclusion Criteria:

          -  Patient refusal to participate to the data collection

          -  Pregnant woman

          -  Patients age is less than 18 years old

          -  The planned intervention is a revision of a previous intervention on the studied hip
             joint

          -  Previous metal implant, except for pure titanium or titanium alloys

          -  Exposure to cobalt and chromium that could influence serum metal ions levels

          -  Planned bilateral intervention

          -  Patient residing outside France

          -  Patient not implanted with a Pinnacle(R) ULTAMET(TM)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marie Toupin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unafiliated</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Genevieve d'Orsay, MD</last_name>
    <role>Study Director</role>
    <affiliation>DePuy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique Herbert</name>
      <address>
        <city>Aix-les-Bains</city>
        <zip>73100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Bonnefon</name>
      <address>
        <city>Ales</city>
        <zip>30104</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Georges Renon</name>
      <address>
        <city>Niort</city>
        <zip>79021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Hilaire</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Royan</city>
        <zip>17200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969 Jun;51(4):737-55.</citation>
    <PMID>5783851</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 12, 2012</lastchanged_date>
  <firstreceived_date>September 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
